The generated ROS can further activate the NF-κB pathway [89], which in turn enhances ROS production [90], forming a positive feedback loop that further promotes osteoblast dedifferentiation, creating a favorable growth environment for prostate cancer bone metastasis. The gene discussed is NFKB1; the disease is prostate carcinoma.